window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

acquisition

  • Movers & Shakers,Partnerships & Funding

    Roquette unveils new organisational structure following IFF Pharma Solutions acquisition

    Company creates two business groups to drive growth across health, [...]

    May 5, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Efzimfotase alfa shows mixed Phase 3 results in hypophosphatasia across pediatric and adult patients
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Research & Development
  • ImmuneOncia Therapeutics and Lonza agree manufacturing partnership for PD-L1 antibody Danburstotug
    Categories: CDMOs & Manufacturing, Cell & Gene Therapy, Immunology, Oncology, Pharmaceuticals and therapeutics, Rare Diseases, Research & Development
  • Vetter recognised as 2026 CDMO Leadership Awards winner in finished dose category
    Categories: CDMOs & Manufacturing, Manufacturing, Market Access & Commercialization, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top